Peter Bumanis, DO
Anesthesiology · Richmond, VANPI 1962499731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 36.0% of the total. Reporting peaked in 2023 at $1,919 and has fallen 97.8% since, to $43 in 2025. Among anesthesiology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 215 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$480
- Johnson & Johnson$247
- Sanofi$164
- Merck$82
- plus $375 from 12 others
What the payments were for
- Food & beverage$4,021100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 80 | $1,447 |
| AbbVie | 62 | $1,226 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $480 |
| Johnson & Johnson | 13 | $247 |
| Sanofi | 7 | $164 |
| Merck | 4 | $82 |
| Amgen | 2 | $54 |
| Ironwood Pharmaceuticals, Inc | 2 | $53 |
| Intercept Pharmaceuticals, Inc. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Nestle Healthcare Nutrition Inc. | 2 | $27 |
| Alnylam Pharmaceuticals Inc. | 2 | $26 |
| Conmed Corporation | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Apollo Endosurgery US Inc | 1 | $18 |
| Pfizer | 1 | $17 |
| Fresenius Kabi USA, LLC | 1 | $16 |
How this compares
$4,021 in reported general payments places this provider in the 95th percentile of 1,065 anesthesiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Richmond
- Jeffrey GreenRichmond$81K
- Nicolas MaxymivRichmond$9K
- John BoothRichmond$8K
- David PalomboRichmond$6K
- Jeannette KierceRichmond$5K
- Marianne MatthewsRichmond$5K
- Andy LiaoRichmond$3K
- Jack CravenRichmond$3K
- David KimRichmond$2K
- Joseph SmithLeesburg$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.